Cadence Design Systems unveiled on Wednesday a new supercomputer based on chips from Nvidia that will speed up its software ...

Vor Bio is the latest cell therapy company to reach the end of the road. | Vor Bio is the latest cell therapy company to ...

Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.

Vinay Prasad, a skeptic of mainstream medicine, is now a top FDA official. Change is coming for some drugmakers, one way or ...

Korro Bio is laying off a fifth of its workforce as the Novo Nordisk-partnered biotech funnels resources to its ...

The 27,000-square-foot center will serve as a hub for advanced livestock reproduction research, education, and outreach, ...

The FDA's decision to appoint Vinay Prasad, MD, MPH, to head its Center for Biologics Evaluation and Research (CBER) raised ...

South Korea has launched a new immigration initiative, the Top-Tier Visa Program (F-2 Resident Visa), targeted at highly skilled foreign ...

BeiGene aims to be a next-generation oncology innovator by broadening its drug and pipeline portfolio to various solid tumors in addition to blood cancers. As such, it been actively investing to build ...

License agreement and recent leadership appointments position Cassava to advance development of simufilam in TSC-related ...

Since the passage of the Inflation Reduction Act, at least 49 research programs and 24 drugs have been discontinued according to Incubate's Life Sciences Investment Tracker. Legislation like the ...

PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS Biotech” or the "Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and infectious ...